Proprotein convertase subtilisin/Kexin type-9 (PCSK-9) inhibitors induced liver injury - a retrospective analysis

• Main Authors: Yousuf Zafar (Author), Yasar Sattar (Author), Waqas Ullah (Author), Sohaib Roomi (Author), Mamoon- (Author), Muhammad Shayan Khan (Author), Laura Schmidt (Author)
• Format: Book
• Published: Greater Baltimore Medical Center, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background Proprotein convertase subtilisin/Kexin type 9 (PCSK-9) inhibitors induced liver dysfunction in patients with or without previous liver injury, and this is not well discussed in the previous literature. Methods A total sample of 202 patients were retrospectively reviewed at the University...